# Benzydamine for Radiation-Induced Oral Mucositis in Patients Receiving High-Dose Radiotherapy

> **NCT07467759** · PHASE4 · COMPLETED · sponsor: **Tishreen University** · enrollment: 35 (actual)

## Conditions studied

- Radiation-induced Oral Mucositis

## Interventions

- **DRUG:** benzydamine hydrochloride
- **OTHER:** saline mouth rinse

## Key facts

- **NCT ID:** NCT07467759
- **Lead sponsor:** Tishreen University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-07-20
- **Primary completion:** 2025-12-25
- **Final completion:** 2025-12-25
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2026-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07467759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07467759, "Benzydamine for Radiation-Induced Oral Mucositis in Patients Receiving High-Dose Radiotherapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07467759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*